Antibiotic Nanomaterial for Commercialisation

Friday, August 21st, 2009

The accelerating rise in antibiotic resistance is driving demand for new and more effective therapies to treat and prevent the spread of bacterial disease. Despite efforts to screen for new antibiotics, microorganisms continue to develop resistance at an increasingly rapid rate to all the therapies available to date. Identification and ...

Posted in Commercial opportunities, Research, medtechinsider | Comments Off